title: De novo aphasic status epilepticus as presenting symptom of multiple sclerosis.
authors.forename: Eugen
authors.initials: E
authors.lastname: Trinka
authors.forename: Iris
authors.initials: I
authors.lastname: Unterberger
authors.forename: Michael
authors.initials: M
authors.lastname: Spiegel
authors.forename: Ulrike
authors.initials: U
authors.lastname: Niedermüller
authors.forename: Thomas
authors.initials: T
authors.lastname: Benke
authors.forename: Thomas
authors.initials: T
authors.lastname: Berger
authors.forename: Gerhard
authors.initials: G
authors.lastname: Bauer
mesh_terms: D000293:Adolescent; D001037:Aphasia / Q000209:etiology* / Q000503:physiopathology*; D001072:Apraxias / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D002220:Carbamazepine / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000473:pathology / Q000503:physiopathology; D003937:Diagnosis, Differential; D004569:Electroencephalography; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology / Q000503:physiopathology*; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D013226:Status Epilepticus / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D016896:Treatment Outcome
chemical_list: D002220:Carbamazepine; D008775:Methylprednisolone